Search - tctmd.com

Displaying 21 - 40 of 212

Sort: Relevancy | Date

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

News Daily News

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Todd Neale

March 20, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

Presentation Miami Valves 2025

Tricuspid valve replacement in a patient with a torn leaflet

Presenter: Joerg Kellermair

January 30, 2025

Presentation Miami Valves 2025

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Percutaneous Tricuspid Valve Intervention (s)

Presenter: Christopher Hawk

January 30, 2025

Presentation Controversies and Advances 2025

FDA Approval for TTVI

Presenter: David J. Cohen

January 30, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Presentation Cardiovascular Interventions 2024

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Presenter: Matthew J. Price

November 11, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

Advertisement

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Tricuspid valve replacement in a patient with a torn leaflet

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

Percutaneous Tricuspid Valve Intervention (s)

FDA Approval for TTVI

Top Structural Heart News of 2024

December 2024 Dispatch for the CV Team

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content